AMRI has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the U.S. with the option to partner on additional drug products. AMRI will work with Ferrer to develop and initially provide cGMP manufacturing and analytical support for the registration of the new product. Accord Healthcare will be responsible for advancing the prod...